Search Results - "GRABEIN, B"

Intravenous fosfomycin—back to the future. Systematic review and meta-analysis of the clinical literature by Grabein, B., Graninger, W., Rodríguez Baño, J., Dinh, A., Liesenfeld, D.B.

“…We conducted a systematic review and meta-analysis to summarize the clinical evidence and usage patterns of intravenous fosfomycin from its development to the…”
Get full text

The ONTAI study – a survey on antimicrobial dosing and the practice of therapeutic drug monitoring in German intensive care units by Liebchen, U., Paal, M., Scharf, C., Schroeder, I., Grabein, B., Zander, J., Siebers, C., Zoller, M.

“…Optimization of antibiotic therapy is still urgently needed in critically ill patients. The aim of the ONTAI survey (online survey on the use of Therapeutic…”
Get full text

Eradication of Acinetobacter baumannii/Enterobacter cloacae complex in an open proximal tibial fracture and closed drop foot correction with a multidisciplinary approach using the Taylor Spatial Frame ® : a case report by Siebenbürger, G, Grabein, B, Schenck, T, Kammerlander, C, Böcker, W, Zeckey, C

“…Multi-drug-resistant bacteria (e.g. Carbapenem-resistant Acinetobacter baumannii, extended-spectrum betalactamase or carbapenemase-producing…”
Get full text

Microbiological analysis of epidermal growth factor receptor inhibitor therapy-associated paronychia by Eames, T, Grabein, B, Kroth, J, Wollenberg, A

“…Background  Paronychia is a well‐known, but difficult to treat cutaneous toxicity associated with epidermal growth factor receptor (EGFR) inhibitor therapy…”
Get full text

Guidelines of the Paul-Ehrlich-Society of Chemotherapy, the German Respiratory Diseases Society, the German Infectious Diseases Society and of the Competence Network CAPNETZ for the Management of Lower Respiratory Tract Infections and Community-acquired Pneumonia by Höffken, G, Lorenz, J, Kern, W, Welte, T, Bauer, T, Dalhoff, K, Dietrich, E, Ewig, S, Gastmeier, P, Grabein, B, Halle, E, Kolditz, M, Marre, R, Sitter, H

Get more information

S3 guideline sepsis-prevention, diagnosis, treatment, and aftercare : Summary of the strong recommendations by Brunkhorst, F M, Weigand, M A, Pletz, M, Gastmeier, P, Lemmen, S W, Meier-Hellmann, A, Ragaller, M, Weyland, A, Marx, G, Bucher, M, Gerlach, H, Salzberger, B, Grabein, B, Welte, T, Werdan, K, Kluge, S, Bone, H G, Putensen, C, Rossaint, R, Quintel, M, Spies, C, Weiß, B, John, S, Oppert, M, Jörres, A, Brenner, T, Elke, G, Gründling, M, Mayer, K, Weimann, A, Felbinger, T W, Axer, H, Heller, T, Gagelmann, N

Get full text

Guidelines for the epidemiology, diagnosis, antimicrobial therapy and management of community-acquired pneumonia and lower respiratory tract infections in adults by Höffken, G, Lorenz, J, Kern, W, Welte, T, Bauer, T, Dalhoff, K, Dietrich, E, Ewig, S, Gastmeier, P, Grabein, B, Halle, E, Kolditz, M, Marre, R, Sitter, H

Get more information

S2k guidelines of the PEG on calculated parenteral initial treatment of bacterial diseases in adults : Focussed summary and supplementary information on antibiotic treatment of critically ill patients by Brinkmann, A, Röhr, A C, Frey, O R, Krüger, W A, Brenner, T, Richter, D C, Bodmann, K-F, Kresken, M, Grabein, B

“…In January 2018 the recent revision of the S2k guidelines on calculated parenteral initial treatment of bacterial diseases in adults-update 2018 (Editor: Paul…”
Get full text

Multidrug resistant gram-negative bacteria : Clinical management pathway for patients undergoing elective interventions in visceral surgery by Eckmann, C, Kaffarnik, M, Schappacher, M, Otchwemah, R, Grabein, B

“…Only a few antibiotics are available for treatment of infections with multidrug resistant gram-negative bacteria (MRGN). The management of patients with MRGN…”
Get full text

New antibiotics for severe infections due to multidrug-resistant pathogens : Definitive treatment and escalation by Richter, D C, Brenner, T, Brinkmann, A, Grabein, B, Hochreiter, M, Heininger, A, Störzinger, D, Briegel, J, Pletz, M, Weigand, M A, Lichtenstern, C

“…Multidrug-resistant pathogens often lead to treatment failure of antimicrobial regimens. After a period of imbalance between the occurrence/spread of…”
Get full text

Bacterial sepsis: Diagnostics and calculated antibiotic therapy by Richter, D. C., Heininger, A., Brenner, T., Hochreiter, M., Bernhard, M., Briegel, J., Dubler, S., Grabein, B., Hecker, A., Kruger, W. A., Mayer, K., Pletz, M. W., Storzinger, D., Pinder, N., Hoppe-Tichy, T., Weiterer, S., Zimmermann, S., Brinkmann, A., Weigand, M. A., Lichtenstern, C.

“…The mortality of patients with sepsis and septic shock is still unacceptably high. An effective calculated antibiotic treatment within 1 h of recognition of…”
Get full text

Infections due to multidrug-resistant pathogens : Pathogens, resistance mechanisms and established treatment options by Richter, D C, Brenner, T, Brinkmann, A, Grabein, B, Hochreiter, M, Heininger, A, Störzinger, D, Briegel, J, Pletz, M, Weigand, M A, Lichtenstern, C

“…The increase in resistant pathogens has long been a global problem. Complicated life-threatening infections due to multidrug-resistant pathogens (MRD)…”
Get full text

Bacterial sepsis : Diagnostics and calculated antibiotic therapy by Richter, D C, Heininger, A, Brenner, T, Hochreiter, M, Bernhard, M, Briegel, J, Dubler, S, Grabein, B, Hecker, A, Krüger, W A, Mayer, K, Pletz, M W, Störzinger, D, Pinder, N, Hoppe-Tichy, T, Weiterer, S, Zimmermann, S, Brinkmann, A, Weigand, M A, Lichtenstern, Christoph

“…The mortality of patients with sepsis and septic shock is still unacceptably high. An effective antibiotic treatment within 1 h of recognition of sepsis is an…”
Get full text

Risk factors for systemic fungal infections in liver transplant recipients by BRIEGEL, J, FORST, H, PETER, K, SPILL, B, HAAS, A, GRABEIN, B, HALLER, M, KILGER, E, JAUCH, K. W, MAAG, K, RUCKDESCHEL, G

“…The risk factors for systemic fungal infections were analysed retrospectively in 186 orthotopic liver transplant procedures performed in 152 patients between…”
Get full text

Results of two worldwide surveys into physician awareness and perceptions of extended-spectrum β-lactamases by Goossens, H., Malhotra-Kumar, S., Eraksoy, H., Unal, S., Grabein, B., Masterton, R., Mendes, C., Garcia-Rodriguez, J.-A., Russo, G., Jones, R.N.

“…An omnibus survey of microbiologists (n = 400) and a survey of participants (n = 49) in the Meropenem Yearly Susceptibility Test Information Collection…”
Get full text

Prevalence and antimicrobial susceptibility data for extended-spectrum β-lactamase– and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997–2004) by Goossens, Herman, Grabein, Béatrice

“…This article presents prevalence and susceptibility data from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Program in Europe…”
Get full text

Strategies for antifungal treatment failure in intensive care units by Arens, C, Bernhard, M, Koch, C, Heininger, A, Störzinger, D, Hoppe-Tichy, T, Hecker, M, Grabein, B, Weigand, M A, Lichtenstern, C

“…Recent epidemiologic studies reveal both an increasing incidence and an escalation in resistance of invasive fungal infections in intensive care units. Primary…”
Get full text

Antibiotic prophylaxis of infectious complications with endoscopic retrograde cholangiopancreatography. A randomized controlled study by Sauter, G, Grabein, B, Huber, G, Mannes, G A, Ruckdeschel, G, Sauerbruch, T

“…Biliary sepsis represents a major percentage of fatal complications after endoscopic retrograde cholangiopancreatography. We performed a randomized controlled…”
Get more information

Relevance of ESBL-producing pathogens for clinical surgery: diagnostics, therapy, and prevention by Lehner, S, Grabein, B, Pfaller, P, Kopp, R

“…Multiresistant, extended spectrum beta lactamase (ESBL)-producing pathogens are an increasing problem in daily clinical life. This paper summarizes the…”
Get full text

Disseminated nocardiosis : Diagnostic challenge by Heyn, J, Ozimek, A, Grabein, B, Heindl, B

“…Nocardiosis is a rarely found bacterial infection in Europe which can particularly affect immunocompromized patients. Localized infections of the dermis and…”
Get full text